Browse diseases

…me; the early outcome was set at 5 years. In addition, specific SLE-related and GC-related, cardiovascular and other forms of damage were a…

…us Erythematosus Disease Activity Index 2000), damage (Systemic Lupus International Collaborating Clinics damage index) and glucocort…

…ng was performed by bulk RNA-sequencing analysis.Results Active SLE patients showed marked downregulation of CD72 on non-naïve CD19…

…onferred an increased risk for CV events in this Latin-American lupus population. Patients with renal lupus were at higher risk. No a…

…utory role of the IFN-induced protein 44-like ( IFI44L) gene in SLE progression and to investigate its transcriptional regulatory m…

…ations unique to lupus. To assess and discuss these issues, the Lupus Accelerating Breakthroughs Consortium, a public–private partner…

…is an under-recognised presenting manifestation of neurological lupus.…

…d Against Lupus (GOAL) cohort (Georgia).Results 221 adults with SLE from the GOAL cohort enrolled in SELF, completing patient-repor…

…afety and durability of telitacicept treatment in patients with SLE by identifying the reasons for treatment discontinuation and po…

… lupus serositis. First, the domain definition and scope in the SLE clinical trial context were defined. Potentially suitable measu…

…ts have suggested that male patients have a more severe form of SLE than female patients but small numbers hamper analysis. Non-whi…

…cioeconomic screening and support strategies into comprehensive SLE management and policy frameworks.…